202 related articles for article (PubMed ID: 32286935)
21. Comparison of outcomes for open versus endoscopic approaches for olfactory neuroblastoma: A systematic review and individual participant data meta-analysis.
Fu TS; Monteiro E; Muhanna N; Goldstein DP; de Almeida JR
Head Neck; 2016 Apr; 38 Suppl 1():E2306-16. PubMed ID: 26514662
[TBL] [Abstract][Full Text] [Related]
22. Esthesioneuroblastoma: irradiation alone and surgery alone are not enough.
Gruber G; Laedrach K; Baumert B; Caversaccio M; Raveh J; Greiner R
Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):486-91. PubMed ID: 12243826
[TBL] [Abstract][Full Text] [Related]
23. Patient characteristics of olfactory neuroblastoma: experience from a tertiary cancer centre 2000-2016 covering Eastern Denmark.
Gram SB; Grønhøj C; Mann H; Jakobsen KK; Kiss K; Bilde A; von Buchwald C
APMIS; 2018 Aug; 126(8):663-666. PubMed ID: 30168622
[TBL] [Abstract][Full Text] [Related]
24. Long-term oncological outcome after endoscopic surgery for olfactory esthesioneuroblastoma.
De Bonnecaze G; Chaput B; Al Hawat A; Filleron T; Vairel B; Serrano E; Vergez S
Acta Otolaryngol; 2014 Dec; 134(12):1259-64. PubMed ID: 25399885
[TBL] [Abstract][Full Text] [Related]
25. Utility of adjuvant chemotherapy in patients receiving surgery and adjuvant radiotherapy for primary treatment of esthesioneuroblastoma.
Miller KC; Marinelli JP; Van Gompel JJ; Link MJ; Janus JR; Foote RL; Price KA; Garcia J; Rivera M; Chintakuntlawar AV
Head Neck; 2019 May; 41(5):1335-1341. PubMed ID: 30536472
[TBL] [Abstract][Full Text] [Related]
26. [Prognostic factors and outcome of esthesioneuroblastoma].
Zhao LJ; Gao L; Xu GZ; Li SY; Xiao GL
Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):561-4. PubMed ID: 16438858
[TBL] [Abstract][Full Text] [Related]
27. Multidisciplinary treatment of olfactory neuroblastoma: Patterns of failure and management of recurrence.
Petruzzelli GJ; Howell JB; Pederson A; Origitano TC; Byrne RW; Munoz L; Emami B; Clark JI
Am J Otolaryngol; 2015; 36(4):547-53. PubMed ID: 25749259
[TBL] [Abstract][Full Text] [Related]
28. [A retrospective study about 11 cases of Esthesioneuroblastomas treated in Hospital Santa Creu i Sant Pau between 2000 and 2008 and literature review].
Muñoz F; Tresserras P; Montserrat JR; Sancho FJ; Bartumeus F
Neurocirugia (Astur); 2011 Oct; 22(5):401-17; discussion 417-8. PubMed ID: 22031159
[TBL] [Abstract][Full Text] [Related]
29. Minimally invasive resection of olfactory neuroblastoma by transnasal endoscopy.
Chang CF; Chiu SC; Yeh SY; Chen MK; Wen YS
Ear Nose Throat J; 2015 Aug; 94(8):E30-6. PubMed ID: 26322455
[TBL] [Abstract][Full Text] [Related]
30. Advantage of Extended Craniofacial Resection for Advanced Malignant Tumors of the Nasal Cavity and Paranasal Sinuses: Long-Term Outcome and Surgical Management.
Sakata K; Maeda A; Rikimaru H; Ono T; Koga N; Takeshige N; Tokutomi T; Umeno H; Kiyokawa K; Morioka M
World Neurosurg; 2016 May; 89():240-54. PubMed ID: 26875653
[TBL] [Abstract][Full Text] [Related]
31. Proposal of a TNM classification-based staging system for esthesioneuroblastoma: More precise prediction of prognosis.
Sun M; Wang K; Qu Y; Zhang J; Zhang S; Chen X; Wang J; Wu R; Zhang Y; Yi J; Xiao J; Xu G; Huang X; Luo J
Head Neck; 2021 Apr; 43(4):1097-1104. PubMed ID: 33301222
[TBL] [Abstract][Full Text] [Related]
32. Neck recurrence and mortality in esthesioneuroblastoma: Implications for management of the N0 neck.
Naples JG; Spiro J; Tessema B; Kuwada C; Kuo CL; Brown SM
Laryngoscope; 2016 Jun; 126(6):1373-9. PubMed ID: 26607219
[TBL] [Abstract][Full Text] [Related]
33. Treatment and outcome in 12 cases of olfactory neuroblastoma at Mexico´s National Cancer Institute: A retrospective clinical analysis and literature review.
Navarro-Fernández JO; Serrato-Avila JL; Hernández-Varela M; Tejada-Pineda MF; Hernández-Reséndiz RE; Monroy-Sosa A; Cacho-Díaz B; Herrera-Gómez Á; Reyes-Soto G
Cir Cir; 2020; 88(4):453-460. PubMed ID: 32567594
[TBL] [Abstract][Full Text] [Related]
34. Endoscopic endonasal management of esthesioneuroblastoma: A retrospective multicenter study.
Nakagawa T; Kodama S; Kobayashi M; Sanuki T; Tanaka S; Hanai N; Hanazawa T; Monobe H; Yokoi H; Suzuki M; Yamashita M; Omori K
Auris Nasus Larynx; 2018 Apr; 45(2):281-285. PubMed ID: 28595773
[TBL] [Abstract][Full Text] [Related]
35. [Long-term experiences in the therapy of esthesioneuroblastoma].
Koch M; Constantinidis J; Dimmler A; Strauss C; Iro H
Laryngorhinootologie; 2006 Oct; 85(10):723-30. PubMed ID: 16673299
[TBL] [Abstract][Full Text] [Related]
36. Clinical features and the molecular biomarkers of olfactory neuroblastoma.
Peng X; Liu Y; Peng X; Wang Z; Zhang Z; Qiu Y; Jin M; Wang R; Kong D
Pathol Res Pract; 2018 Aug; 214(8):1123-1129. PubMed ID: 29921494
[TBL] [Abstract][Full Text] [Related]
37. Multicenter assessment of exclusive endoscopic endonasal approach for the treatment of 53 olfactory neuroblastomas.
de Gabory L; Verillaud B; Rumeau C; Herman P; Jankowski R; Michel J; de Kermadec H; Coste A; Mortuaire G; Righini C; Reyt E; Choussy O; Trévillot V; Crampette L; Serrano E; Tsaranazy A; Bastier PL; Vergez S
Head Neck; 2018 May; 40(5):1000-1007. PubMed ID: 29356209
[TBL] [Abstract][Full Text] [Related]
38. Esthesioneuroblastoma in childhood and adolescence. Better prognosis with multimodal treatment?
Eich HT; Müller RP; Micke O; Kocher M; Berthold F; Hero B
Strahlenther Onkol; 2005 Jun; 181(6):378-84. PubMed ID: 15925980
[TBL] [Abstract][Full Text] [Related]
39. Development of an evaluation and treatment strategy for olfactory neuroblastoma: a review of evidence from large-scale studies, including population-based and multicenter studies, and meta-analyses.
Ariizumi Y; Asakage T
Jpn J Clin Oncol; 2024 May; ():. PubMed ID: 38762332
[TBL] [Abstract][Full Text] [Related]
40. Optimal treatment and prognostic factors for esthesioneuroblastoma: retrospective analysis of 187 Chinese patients.
Xiong L; Zeng XL; Guo CK; Liu AW; Huang L
BMC Cancer; 2017 Apr; 17(1):254. PubMed ID: 28399835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
